Mabwell Embarks on New Medical Milestone in China with MAIWEIJIAN Approval
Mabwell, a leading biopharmaceutical company, has reached a significant milestone as the National Medical Products Administration (NMPA) approved the supplemental Biologics License Application for MAIWEIJIAN in China.
For the prevention.....
Subscribe for Full Access!
Gain valuable sourcing and trade intelligence from our database of millions of data points spanning 20+ years!
